Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers-Reference-Cited by-同舟云学术

Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers

Published:2020-04 Issue:7 Volume:28 Page:115379
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Wan Zhong,Jiang Huabo,Li Li,Zhu Shuhui,Hou Jingjing,Yu Yongsheng

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Research Foundation

Tongji University

Fujian Provincial Department of Science and Technology

Xiamen Municipal Bureau of Science and Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference128 articles.

1. The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors;Panousis;Eur J Gynaecol Oncol,2011

2. Epigenetic factors in cancer development: polycomb group proteins;Piunti;Future Oncol,2011

3. The polycomb complex PRC2 and its mark in life;Margueron;Nature,2011

4. The EZH2 polycomb transcriptional repressor—a marker or mover of metastatic prostate cancer?;Sellers;Cancer Cell,2002

5. The polycomb group protein EZH2 is involved in progression of prostate cancer;Varambally;Nature,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion;Molecular and Cellular Biochemistry;2023-05-18

2. The Interplay between Noncoding RNAs and p21 Signaling in Gastrointestinal Cancer: From Tumorigenesis to Metastasis;Current Pharmaceutical Design;2023-03

3. Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer;Bioinformatics and Biology Insights;2022-01

4. Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential;Expert Opinion on Therapeutic Targets;2021-12-02

5. T herapeutic targeting of chromatin: status and opportunities;The FEBS Journal;2021-06-25